# MiraTyper by MiraOmics

> MiraTyper provides cell typing and malignant calls for single-cell, spatial and H&E data. Capabilities and validation depend on the assay and panel.

The 425 Cell Ontology types describe the RNA classifier, not the H&E workflow. Use the technical details and each case study for evidence and limitations. Planned capabilities are not current validation results.

## Product

- [MiraTyper summary](https://miratyper.ai/index.md): Inputs, outputs, platform coverage, training-scale distinction, deployment, and trial/contact links in Markdown.
- [Technical details](https://miratyper.ai/technical/): Assay-specific benchmarks, evaluation settings, FAQs, and limitations.
- [Supported technologies](https://miratyper.ai/#supported-platforms): Current platform table, including prototype status.

## Evidence and applications

- [Case studies](https://miratyper.ai/case-studies/): Published H&E, spatial, and single-cell examples.
- [Translation](https://miratyper.ai/use-cases/translation/): Cohort selection, cohort expansion, and reverse translation.
- [Discovery](https://miratyper.ai/use-cases/discovery/): Biological discovery applications.

## Company and contact

- [About MiraOmics](https://miratyper.ai/about/): Leadership and partners.
- [Try MiraTyper free](https://miratyper.ai/#free-trial): Name/email capture followed by scheduling for two free dataset runs.
- [Contact](https://miratyper.ai/contact/): Email and message form.